Page 44 - Sohini Das

Be cautious about 'excessive use' of booster Covid doses: Srinath Reddy

Surveillance for new variants of the virus must continue, says distinguished professor at PHFI

Pharma industry seeks graded introduction of trade margin rationalisation

TMR may be applied in phases, with the first one including drugs priced above Rs 100 or so

Under the lens: Regulator moots pre-export govt testing for cough syrup cos

A pharma industry veteran said that the government may consider making glycol testing compulsory for all manufacturers of syrups and solvents

How Covid-19 waves are turning into ripples; dip in latest surge fastest

The fourth time that the 10,000-mark was breached was in April 2023. The latest spike lasted 7 days-the shortest of the four.

Tata Motors reports net profit of Rs 5,408 crore in Q4, revenue surges 35%

The company board has recommended a final dividend of Rs 2 per ordinary share

No plans to sell stake in consumer healthcare biz: Sanofi India MD Hrosz

'Our insulin portfolio today offers best-in-class insulin for better diabetes management'

PV dispatches highest ever in April, grow 13% YoY, shows SIAM data

2W dispatches up 15% YoY, auto body says all segments have posted growth this April, indicating smooth shift to BS VI Phase 2 emission norms

Pricing regulator sets mechanism to fix prices of off-patent drugs

Prices to be capped at 50% of innovator price; to be reviewed after one year

Sanofi consumer brands get a shot in the arm on demerger decision

Demerging the pharma business will help the company focus on niche therapy areas, including bringing its global pipeline to India

Sanofi consumer brands get a shot in the arm on demerger decision

Sanofi Consumer Healthcare India is expected to be listed on both the BSE and NSE, the company said in an exchange notification

Dr Reddy's Laboratories Q4 PAT grows nine-fold riding on US, India biz

For the full year 2022-23, DRL's revenues were up 15 percent to Rs 24,587.9 crore while the PAT grew by 91 percent to Rs 4,506.7 crore

Lupin reports 12% rise in Q4 sales riding on API, US and India biz

The revenue growth came from a strong API business performance along with US and domestic market sales growth

Govt, industry meet to focus on trade margin rationalisation of drugs

The Centre has been mulling on rationalizing drug trade margins for a while now for widely used medicines in an effort to bring down prices

Drug sales stuck at pre-pandemic level, price rise shapes market growth

Respiratory medicines doing well as people recover from long-term effects of Covid-19

Likely $10-billion injection: India's medtech a picture of health

Centre notifies the National Medical Devices Policy, 2023

India's contribution to global clinical trials at 4% during 2010-22: Study

Top 20 pharma-sponsored trials in the country has increased by 10 per cent since 2013

Luxury car maker Audi India starts production of Q3 SUV at Aurangabad plant

Audi was planning to make these cars in India along with the Audi Q5, A6, A4, Q7

El Nino unlikely to dampen tractor industry volumes in a big way

Likely El Niño may water down sentiment but industry does not see huge downside in sales in FY24

Indo-French team designing novel molecule to slay Covid-19 infection

Covid-19 is a complex disease with short-term as well as long-term respiratory, inflammatory and neurological symptoms that are triggered by the infection by Sars-CoV-2 virus

Mahindra and Mahindra gears up for EV play, niche e-farm products

M&M aims to make 200,000 EVs a year around 2027